4-(2-(2-Bromophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine

Catalog No. :
ACRXOM747
CAS No. :
384820-17-1
Molecular Formula :
C20H13BrFN3
Molecular Weight :
394.25

IUPAC Name:4-(2-(2-bromophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine

4-(2-(2-Bromophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-(2-Bromophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine
IUPAC Name4-(2-(2-bromophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine
Molecular FormulaC20H13BrFN3
Molecular Weight394.25
SMILESBrC1=C(C2=NC(C3=CC=C(F)C=C3)=C(C4=CC=NC=C4)N2)C=CC=C1
InChI KeyCOVWDRBCMJOSQM-UHFFFAOYSA-N
SynonymPyridine, 4-[2-(2-broMophenyl)-4-(4-fluorophenyl)-1H-iMidazol-5-yl]-;4-[2-(2-bromophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]Pyridine;4-[2-(2-Bromophenyl)-5-(4-fluorophenyl)-1H-imidazol-4-yl]pyridine
CAS No.384820-17-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRXOM747 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSPWM723 route compound structure diagram
    ACSPWM72357075-82-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRXOM747 route product structure diagram
    ACRXOM747384820-17-1
Inquiry

2. ACRXOM747 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSPWM723 route compound structure diagram
    ACSPWM72357075-82-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRXOM747 route product structure diagram
    ACRXOM747384820-17-1
Inquiry

Comments (0)